Clinical Trials List
Protocol NumberCFAZ053X2101
Completed
2016-10-20 - 2024-11-22
Phase I
Terminated1
ICD-9190.0
Malignant neoplasm of eyeball, except conjunctiva, cornea, retina and choroid
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Jih-Hsiang Lee 無
- JIN-YUAN SHIH 無
- 許嘉林 無
- 張端瑩 無
- 徐偉勛 無
- 陳冠宇 無
- 蔡子修 無
- Wei-Wu Chen 無
- James Chih-Hsin Yang 無
- Chong-Jen Yu 無
- 廖唯昱 無
- 林季宏 無
- 廖斌志 無
- CHAO-CHI HO CHAO-CHI HO 無
- YEN-SHEN LU 無
- Wen-Fang Cheng 無
The Actual Total Number of Participants Enrolled
0 Completed
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8-16 participants
-
Global
154 participants
